Inhibition of T-cell response by Escherichia coli heat-labile enterotoxin-treated epithelial cells.
Escherichia coli heat-labile enterotoxin (LT) is an extensively studied adjuvant of mucosal responses. Nevertheless, its mode of action as an adjuvant remains incompletely understood. In this study, we describe a simplified in vitro model with which to look at some aspects of immunoregulation by LT. The interaction of LT with the apical surface of a monolayer of CaCo-2 epithelial cells induces the release of a soluble factor which inhibits the antigen-induced release of interleukin-2 by T cells cultured at the basolateral side of the cells. The release of this factor requires the ADP-ribosylating activity of LT since the isolated B subunit, as well as an enzymatically silent LT mutant, loses biological activity in this model. The inhibitory activity is likely to be due to prostaglandin release, since it is blocked by indomethacin. The contribution of LT-induced prostaglandin release to the complex immunoregulatory activity of LT is discussed.
Lopes
L M
LM
Department of Immunology, Windeyer Institute of Medical Sciences, University College London, London W1P 6DB, United Kingdom.
Maroof
A
A
Dougan
G
G
Chain
B M
BM
D001427:Bacterial Toxins / Q000633:toxicity*; D018938:Caco-2 Cells; D000242:Cyclic AMP / Q000096:biosynthesis; D004768:Enterotoxins / Q000633:toxicity*; D004926:Escherichia coli / Q000472:pathogenicity*; D029968:Escherichia coli Proteins; D005677:G(M1) Ganglioside / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D005677:G(M1) Ganglioside; C027538:heat-labile enterotoxin, E coli; D000242:Cyclic AMP; D007213:Indomethacin